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Mitochondrial dysfunction has been implicated in the
pathogenesis of acute kidney injury due to ischemia and
toxic drugs. Methods for imaging mitochondrial function in
cells using confocal microscopy are well established; more
recently, it was shown that these techniques can be utilized
in ex vivo kidney tissue using multiphoton microscopy. We
extended this approach in vivo and found that kidney
mitochondrial structure and function can be imaged in
anesthetized rodents using multiphoton excitation of
endogenous and exogenous fluorophores. Mitochondrial
nicotinamide adenine dinucleotide increased markedly in rat
kidneys in response to ischemia. Following intravenous
injection, the mitochondrial membrane potential–dependent
dye TMRM was taken up by proximal tubules; in response to
ischemia, the membrane potential dissipated rapidly and
mitochondria became shortened and fragmented in proximal
tubules. In contrast, the mitochondrial membrane potential
and structure were better maintained in distal tubules.
Changes in mitochondrial structure, nicotinamide adenine
dinucleotide, and membrane potential were found in the
proximal, but not distal, tubules after gentamicin exposure.
These changes were sporadic, highly variable among
animals, and were preceded by changes in non-
mitochondrial structures. Thus, real-time changes in
mitochondrial structure and function can be imaged in
rodent kidneys in vivo using multiphoton excitation of
endogenous and exogenous fluorophores in response to
ischemia–reperfusion injury or drug toxicity.
Kidney International (2012) 83, 72–83; doi:10.1038/ki.2012.328;
published online 19 September 2012
KEYWORDS: acute kidney injury; gentamicin; in vivo microscopy; ischemia;
mitochondria; multiphoton imaging
Mitochondria have a variety of important intracellular
functions, including ATP production (via oxidative phos-
phorylation), synthesis of reactive oxygen species (ROS),
modulation of Ca2þ signals, and regulation of cell death
pathways (for review see Duchen et al.1). Mitochondrial
dysfunction has been implicated in the pathogenesis of a
range of renal diseases, including ischemic-2–7 and drug-
induced8,9 acute kidney injury (AKI). The proximal tubule
(PT) is densely packed with mitochondria and is frequently
the major site of damage in AKI. To understand more about
the underlying mechanisms and develop novel protective
strategies, new technological approaches are required that
will enable the study of mitochondrial function in the kidney
in vivo in animal models of AKI.
Previous studies on mitochondria in the kidney have
relied mainly on morphological analysis with electron
microscopy, on measures of tissue oxygen consumption, or
on respiratory chain function tests conducted on isolated
organelles (which can become damaged during the isolation
process).10 Methods for studying a variety of mitochondrial
functions in situ in intact cells using fluorescence microscopy
are well established;11 however, PT-derived immortalized cell
lines can differ greatly in their metabolism from native PT,12
and the usage of primary tissue is therefore preferable.
Confocal microscopy of freshly isolated PTs has been used to
gain important insights into the effects of hypoxia on
mitochondrial function.6,13 Multiphoton microscopy allows
greater tissue penetration, with less phototoxicity, compared
with conventional confocal imaging; it thus provides the
potential to transfer imaging approaches established in
isolated cells and tubules to intact sections of tissue. It has
been demonstrated recently that a range of aspects of
mitochondrial function can be imaged ex vivo in live slices
of rat kidney14 and intact isolated perfused organs15 using
multiphoton microscopy. Imaging intact tissue with a
preserved architecture enables the direct comparison of
signals between different cell types, and an initial study
using this novel approach has suggested that mitochondrial
function varies along the nephron, both at rest and in
response to ischemia.
Multiphoton microscopy of the rodent kidney in vivo is
now an established and powerful technique in renal research
(e.g. see Molitoris et al.16 and Sipos et al.17), and in the
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present study we have demonstrated that it can be applied to
image mitochondrial function in the kidneys of anesthetized
rodents, both at rest and in models of ischemia- and
gentamicin-induced AKI, by using appropriate endogenous
and exogenous fluorophores.
RESULTS
In vivo imaging of mitochondrial nicotinamide adenine
dinucleotide (NADH) and membrane potential
The PT in the rodent kidney emits a large amount of
autofluorescence in vivo; we found that the blue autofluo-
rescence signal in mice and rats was dominated by mito-
chondrial NADH (Figure 1a and b), which was optimally
excited at 720–760 nm. NADH is the substrate for respiratory
chain complex I, but the oxidized form of the molecule
(NADþ ) is not fluorescent;18 hence, the emitted fluorescence
signal reflects the proportion of the total NAD pool that is in
a reduced state at any given time. The origin of the NADH
signal was confirmed by colocalization with tetramethyl
rhodamine methyl ester (TMRM) and also by a marked
increase in intensity in response to ischemia (see below—
‘Real-time in vivo imaging of mitochondrial structure and
function during ischemia-reperfusion’). Nicotinamide
adenine dinucleotide phosphate (NADPH) has similar
spectral properties to NADH; however, we observed
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Figure 1 | In vivo imaging of mitochondrial nicotinamide adenine dinucleotide (NADH) and membrane potential in the kidney.
(a, b) Mitochondrial NADH was visible at 720 nm excitation in both mouse (a) and rat (b) kidneys and showed a characteristic basolateral
mitochondrial distribution in tubular cells (arrow), with very little fluorescence signal observed in non-mitochondrial structures including the
apical brush border (arrowhead) or cell nuclei (asterisk). (c–g) The mitochondrial membrane potential (DCm)–dependent dyes tetramethyl
rhodamine methyl ester (TMRM) and rhodamine 123 loaded into rodent kidney tubules and localized to the mitochondria; TMRM loaded well
into rat proximal tubules (PTs—arrow), distal tubules (DTs—arrowheads), and glomeruli (asterisk) following intravenous injection (c), whereas
rhodamine 123 loaded well into PTs (arrow), but not DTs (arrowheads) or glomeruli (asterisk) (d). Uptake of TMRM into tubules occurred initially
from the basolateral side (arrow) (e); images depicted were acquired shortly after an intravenous injection of the dye into a mouse.
Representative traces are depicted showing the rapid increase and subsequent slow decrease in fluorescence that occurred in rat PTs following
intravenous injection of TMRM and rhodamine 123 (f). Representative traces are depicted showing that the decline of TMRM fluorescence in rat
PTs was not prevented by prior intravenous injection of either cimetidine or verapamil (g); no decline in TMRM fluorescence was observed in
DTs. Bars¼ 20 mm in (a, b) and 40mm in (c, d).
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mitochondria (Figure 1b), suggesting that cytosolic NADPH
does not contribute significantly to the emitted signal.
The autofluorescence signal in the green range was bright
across a range of excitation wavelengths (700–850 nm) and
consisted principally of two components: one mitochondrial
in origin and the other non-mitochondrial, probably origi-
nating from lysosomes.19,20 The latter signal was present only
in PTs and not in the distal tubules (DTs). The mitochondrial
green signal at lower excitation wavelengths (o800 nm)
partly consisted of bleed-through from NADH, as the
intensity was observed to increase in response to ischemia;
however, there was also another component visible at higher
excitation wavelengths (4800 nm) that may represent
oxidized flavoproteins (FAD2þ ),14,21,22 but the signal was
too weak to consistently define confirmatory changes in
response to ischemia.
Mitochondrial membrane potential (DCm) lies at the
heart of the mitochondrial function, determining the rates of
key processes such as ATP production, ROS generation, and
Ca2þ uptake. TMRM and rhodamine 123 are lipophilic
cationic dyes that accumulate in the mitochondria according
to DCm;11 following intravenous injections, rapid uptake of
these dyes was observed within seconds in PT cells in both
mice and rats, predominantly from the basolateral side
(Figure 1c–e). TMRM also loaded well into DTs and
glomeruli (Figure 1c), but there was relatively little
rhodamine 123 uptake into these structures (Figure 1d),
suggesting that TMRM is a more useful dye for measuring
DCm in rodent kidneys in vivo.
Both TMRM and rhodamine 123 fluorescence signals
decreased gradually over time in PTs following intravenous
injection (Figure 1f). We postulated that the decay in signal
in PTs could have been because of dye extrusion by cell
membrane efflux pumps; TMRM and rhodamine 123 are
both substrates for the MDR (P-glycoprotein),23 and the
renal tubule also contains organic cation transporters that
have been shown to facilitate efflux of fluorescent cationic
molecules in vivo.24 However, we found that neither
verapamil (an inhibitor of the MDR25) nor cimetidine (an
inhibitor of organic cation transporters26) prevented the
decay of TMRM signal in the PTwhen injected intravenously
10min before the injection of dye; in contrast to PTs, TMRM
signal in DTs did not decay over time (Figure 1g).
ROS and glutathione
The mitochondrial respiratory chain is a major source of
intracellular ROS production in vitro,27 but very little is
known about the relative contributions of various ROS-
generating pathways in vivo. Dihydroethidium (HEt) emits a
fluorescence signal in the red range in the presence of
superoxide and is widely used as a marker of intracellular
ROS production. Following intravenous injection of HEt in
rats, an increase in fluorescence signal was noted within
minutes in tubular cells, which localized predominantly
to the mitochondria (as demonstrated by colocalization
with NADH), and, although the intensity of signal was
heterogeneous across the cortex, it was markedly higher in
PTs in comparison with adjacent DTs (Figure 2a–c). These
findings are consistent (i) with mitochondria being a major
source of ROS production in tubular cells in vivo and (ii)
with a higher rate of ROS generation in PTs than in DTs. This
is in agreement with previous ex vivo studies on ROS
production in the rodent kidney; however, in vivo we did not
observe the nuclear HEt signal that also occurs in vitro.14
Glutathione is a major intracellular antioxidant that also
has important roles in drug metabolism in the PT.
Monochlorobimane (MCB) is a nonfluorescent dye that
binds to glutathione to form a fluorescent adduct, and it has
been used previously in vitro to obtain steady-state measure-
ments of glutathione levels in tubular cells.14 Following
intravenous injection of MCB in rats, we observed an
increase in fluorescence in PT cells within minutes that
originated at the basolateral side and spread apically over
time (Figure 2d–e), likely representing uptake of MCB bound
to circulating glutathione, and/or uptake of unbound MCB
that subsequently reacted with intracellular glutathione.
Relatively little increase in fluorescence signal was noted in
DTs. Shortly thereafter, the fluorescence signal decreased
again in PT cells but increased in the tubular lumens
(Figure 2f), consistent with active apical excretion of MCB/
glutathione; the increase in luminal fluorescence was unlikely
to represent filtered circulating MCB/glutathione as we did
not observe any fluorescence signal in the vascular lumens. At
20min after injection, the MCB signal had mostly disap-
peared from PTs, but the fluorescence signal remained high
in endothelial cells (Figure 2g) and the dye became
concentrated in the DT lumens (Figure 2h).
Real-time in vivo imaging of mitochondrial structure and
function during ischemia reperfusion
Ischemia–reperfusion injury is a major cause of AKI in
nephrology and transplantation. We explored the feasibility
of imaging changes in the mitochondrial structure and
function in real time in the rat kidney during ischemia–
reperfusion. A ligature was placed around the left renal artery,
which could be tightened to induce ischemia and then
relaxed to allow reperfusion, while simultaneously acquiring
images. The mitochondrial NADH signal increased rapidly
and markedly in response to ischemia (Figure 3a–d), and
decreased again on reperfusion. These changes confirmed the
identity of the signal, and the magnitude of the signal
increase observed in response to ischemia supports previous
in vitro data showing that under resting conditions the
mitochondrial NADH pool is in a relatively oxidized state in
the PT.14
Induction of ischemia caused an abrupt decrease in the
TMRM signal in PTs (Figure 3e and f), implying rapid
depolarization of mitochondria in this nephron segment. The
rate of signal decline was considerably faster than that
observed in control experiments (Figure 1f). Very little
further decrease in signal was observed over time during
ischemia (Figure 3g), consistent with the previous data from
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kidney slices, which demonstrated that mitochondria in the
PT are almost fully depolarized after only a short period of
ischemia.14 In contrast to the PT, DCm was better maintained
in the DT during ischemia in tissue slices; following the
induction of ischemia, in vivo DCm in DTs decreased more
rapidly than in the in vitro studies but was still maintained
for a longer duration than in PTs (Figure 3h). After 30min of
ischemia, the mitochondria in DTs in vivo appeared fully
depolarized; however, DCm was maintained to a greater
extent in the cortical collecting ducts, as demonstrated by a
significantly higher mean mitochondrial TMRM signal
intensity (24.5±5.9 A.U. vs. 9.5±5.0 A.U., n¼ 3, Po0.05)
(Figure 3i and j).
Mitochondrial function is inextricably linked with mor-
phology; changes in mitochondrial morphology in PTs have
been described in response to hypoxia using electron
microscopy6 and in response to ischemia–reperfusion injury
using confocal imaging of live kidney slices.2 It is believed
that mitochondrial fragmentation in the PT may have an
important role in the release of proapoptotic factors and
initiation of cell death during ischemic AKI.3 As described
above, NADH signal increased markedly in the PT in
response to cessation of blood flow and we were able to
utilize this bright signal to achieve sufficient optical
resolution to obtain detailed images of mitochondrial
morphology during ischemia. Mitochondria in the PT are
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Figure 2 | In vivo imaging of reactive oxygen species (ROS) production and glutathione in the kidney. (a–c) Imaging of ROS production.
Following intravenous injection of the reactive ROS-sensitive dye dihydroethidium (HEt) in rats, the fluorescence signal was higher in proximal
tubules (PTs—arrow) than in adjacent distal tubules (DTs—arrowhead) (a); simultaneous excitation of mitochondrial nicotinamide adenine
dinucleotide (NADH) (blue) (b) showed that the two signals colocalized (c). (d–h) Imaging of intracellular glutathione using monochlorobimane
(MCB). Following intravenous injection of MCB in rats, an increase in fluorescence signal intensity was observed in PTs, which originated at the
basolateral aspect of cells and spread apically over time (d, e), with simultaneous uptake into endothelial cells (arrow). MCB was subsequently
rapidly excreted from PT cells (arrow) into the tubular lumen (arrowhead) (f); the image depicted was acquired 8min post injection. Although MCB
was excreted by PTs, the signal remained stable in endothelial cells (arrow) (g); the image depicted was acquired 18min post injection. After 20min,
the fluorescence signal had disappeared from PTs (arrow) but was visible in DT lumens (arrowhead) (h). Bars¼ 20mm in all images.
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normally elongated (Figure 3k) but became shortened and
fragmented after just 10min of ischemia (Figure 3l).
Interestingly, although mitochondria in the DT were
depolarized after 30min of ischemia, mitochondrial mor-
phology was comparatively well preserved compared with
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After 45min of ischemia, kidneys preloaded with TMRM
were reperfused; shortly thereafter, the mitochondrial fluores-
cence signal in the tubular cells was observed to increase with a
parallel decrease in the cytosolic signal, implying redistribution
of TMRM from the latter compartment to the former because
of recommencement of respiratory chain activity and reenergi-
zation of mitochondria (Figure 3o). Cell shedding has been
described in the PT during ischemia–reperfusion injury,28 and
we observed cells moving along the lumen during reperfusion.
Some of these cells emitted a bright TMRM signal (Supple-
mentary Movie S1 online), suggesting that mitochondria
were energized in spite of cell detachment, consistent with
the notion that these cells can remain viable.29 Following
exposure to 45min of ischemia and 20min of reperfusion,
mitochondria in the PT remained shortened and fragmented
when compared with control animals (Figure 3n).
In vivo imaging of mitochondrial structure and function in
gentamicin toxicity
The kidney is a major excretory pathway for xenobiotics, and
drug toxicity is an important cause of renal disease. The
aminoglycoside antibiotic gentamicin is commonly asso-
ciated with cases of AKI; previous in vivo imaging studies
have demonstrated its uptake in the PT,30 and histological
and in vitro studies have implicated mitochondrial dys-
function as a key step in the pathogenesis of gentamicin-
induced nephrotoxicity.31–35 Furthermore, mitochondrial
dysfunction is believed to occur before the onset of
functional or morphological evidence of severe kidney
injury.32 We explored the effects of gentamicin on
mitochondrial function in the rat kidney in vivo by using a
well-established model (intraperitoneal injection of
gentamicin 100mg/kg once daily), which reliably produces
AKI and a progressive increase in serum creatinine.36
Animals were imaged at different time points to explore
temporal changes in mitochondrial structure and function.
A marked increase in size in non-mitochondrial organelles
emitting bright green autofluorescence was observed in PTs
after just 1 day of gentamicin exposure (Figure 4a); these
structures most likely represented enlarged lysosomes con-
taining lipofuscin.19,20,31 After 2 days, subtle abnormalities
occurred in the luminal brush border of PTs, with more
severe loss of structure in some areas; these changes became
pronounced and widespread by 4 days (Figure 4a). In
contrast to these abnormalities, mitochondrial structure and
function were preserved after 2 days of gentamicin exposure
(Figure 4a). After 4 days of exposure, there was evidence of
mitochondrial dysfunction in some PTs, with abnormal
structure and increased NADH signal (Figure 4a). However,
these changes were sporadic and were not present in all
animals at 4 days; overall, mitochondria in the majority of
PTs remained well energized, and there was no significant
difference in mean PT mitochondrial NADH fluorescence
(day 0: 28.6±1.8 A.U.; 1–2 days: 30.6±2.0; 4 days: 29.6±4.4;
n¼ 4 in all groups; P¼ 0.90) (Figure 4d) or mean mito-
chondrial TMRM fluorescence (day 0: 29.6±3.6 A.U.; 1–2
days: 34.0±4.0; 4 days: 21.2±3.9; n¼ 4 in all groups;
P¼ 0.11) (Figure 4e).
After 6 days of gentamicin exposure, abnormalities in PT
mitochondrial structure and function were observed in all rats,
but the extent of these remained highly variable among animals.
Furthermore, PTs containing grossly dysmorphic mitochondria
with high NADH signal and low DCm were observed to coexist
directly adjacent to other PTs with normal appearances
(Figure 4a), emphasizing the sporadic nature of gentamicin-
induced damage in the kidney. After 8 days of gentamicin
exposure, extensive cell death was observed in PTs, leading to
the existence of ‘ghost tubules’ containing no viable cells
(Figure 4b). Within the few surviving PTs, mitochondria were
swollen and dysmorphic, and DCm was highly variable among
adjacent cells within the same tubule (Figure 4a). In contrast,
mitochondrial morphology and function remained preserved
within DTs and collecting ducts (Figure 4c).
In summary, these observations support the notion that
gentamicin toxicity in the kidney is specifically targeted
toward the PT and causes abnormalities in mitochondrial
structure and function in this nephron segment; however, the
timing and extent of damage is highly variable both among
and within animals, and changes in other aspects of cell
ultrastructure (including the apical brush border and
lysosomes) precede abnormalities in mitochondria. Ulti-
mately, these changes lead to cell death in the majority of PTs.
Figure 3 | Real-time in vivo imaging of mitochondrial structure and function in the kidney during ischemia reperfusion. (a–d) Resting
nicotinamide adenine dinucleotide (NADH) signal in rat renal cortical tubules (a) increased markedly in response to ischemia (b); the image depicted
was acquired 2min post occlusion of the renal artery; higher resolution images acquired pre- (c) and post-ischemia (d) confirmed that the signal
change was localized to the mitochondria. (e–g) In rat proximal tubules (PTs) loaded with tetramethyl rhodamine methyl ester (TMRM), resting
mitochondrial membrane potential (DCm) (e) dissipated rapidly in response to ischemia (f); the image depicted was acquired 2min post ischemia;
data depicted in (g) are mean (±s.e.m.) mitochondrial TMRM fluorescence intensity in PTs of three separate experiments. DCm was better
maintained during ischemia in distal tubules (DTs—arrowhead) than in PTs (arrow) (h); the image depicted was acquired 9min post ischemia. After
30min of ischemia, DCm was better maintained in collecting ducts (arrow) than in DTs (arrowhead) (i); data depicted in (j) are mean (±s.e.m.) of
mitochondrial TMRM fluorescence of three separate experiments (*Po0.05). (k–n) Changes in mitochondrial morphology during ischemia and
reperfusion. Images depicted show the following: normal elongated mitochondria in PTs loaded with TMRM (k); NADH signal in a PT 10min post
ischemia demonstrating widespread mitochondrial shortening and fragmentation (l); NADH signal 30min post ischemia demonstrating normal
mitochondrial morphology in a DT (arrowhead) adjacent to a PT (arrow) (m); fragmented mitochondria 20min post reperfusion in a PT loaded with
TMRM (n). The signal intensity gain was adjusted in images (k–n) to optimally visualize mitochondrial structure. (o) Repolarization of mitochondria
immediately post reperfusion in ischemic PTs preloaded with TMRM; images depicted were acquired 50 s apart and demonstrate a spreading wave
of repolarization (arrows) from a central blood vessel (asterisk), with reuptake of TMRM from the cytosolic compartment into the mitochondria
within cells. Bars¼ 40mm in (a, b) and (e, f) and 20mm in all other images.
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DISCUSSION
We have demonstrated that mitochondrial structure and
function can be imaged in both mouse and rat kidneys in vivo
using multiphoton excitation of endogenous and exogenous
fluorophores. Furthermore, changes in signal can be followed
in real time in response to ischemia–reperfusion injury or
drug toxicity, the most common causes of AKI in nephrology
and transplantation. We therefore believe that this approach
will be useful in understanding the roles of mitochondria in
renal diseases and in evaluating the effects of future
mitochondrial targeted therapies.
Multiphoton microscopy has been used to image various
aspects of kidney function in live animals;16,17 we have
now shown that it can be utilized to transfer established
in vitro techniques for measuring mitochondrial function
using fluorescence microscopy to the in vivo situation.
Mitochondrial NADH can be imaged in the kidney and
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Figure 4 | In vivo imaging of gentamicin toxicity in the kidney. (a–c) Representative images are depicted displaying the time course of
intracellular changes in gentamicin toxicity. After 1–2 days of exposure, bright structures were visible in the proximal tubules (PTs) in the green
autofluorescence (AF) signal (arrow), most likely representing enlarged lysosomes, which were not visible in the distal tubules (DTs—
arrowhead); after 4 days, abnormalities were also noted in the PT brush border (arrow). Mitochondrial nicotinamide adenine dinucleotide
(NADH) signals remained normal in tubules at 1–2 days; after 4 days, sporadic areas of dysmorphic mitochondria and increased NADH signal
were observed in PTs (arrow), but not in DTs (arrowhead). However, the majority of mitochondria in PTs loaded with the mitochondrial
membrane potential (DCm)–dependent dye tetramethyl rhodamine methyl ester (TMRM) appeared well energized up to 4 days. After 6 days,
abnormalities in NADH signal were more widespread in PTs, but remained highly variable, with damaged tubules (arrow) appearing directly
adjacent to normal-looking tubules (arrowhead); a high degree of variability was also observed in mitochondrial TMRM signal intensity. After 8
days, mitochondria in the surviving PTs were grossly dysmorphic, as seen in the NADH image, and massively enlarged lysosomes were visible in
the green AF signal (arrow); there were also marked variations in mitochondrial TMRM signal between adjacent cells within surviving PTs. After
8 days of gentamicin exposure, widespread necrosis occurred in PTs, leading to the appearance of ghost tubules devoid of living cells (arrow)
(b); in contrast, mitochondrial NADH (b) and TMRM (c) signals remained normal in DTs (arrowhead) and collecting ducts (arrow). (d, e) Data
depicted show mean mitochondrial NADH (d) and TMRM (e) fluorescence intensity (±s.e.m.) after exposure to gentamicin; n¼ 4 animals in
each group. Bars¼ 20 mm in all images.
78 Kidney International (2012) 83, 72–83
bas i c resea rch AM Hall et al.: In vivo multiphoton imaging of mitochondrial function in the kidney
occurred at 720–760 nm, which is in agreement with studies
using other tissues.22,37,38 The identity of the signal was
confirmed by its mitochondrial localization and by
characteristic changes in intensity in response to
ischemia.39 The magnitude of the increase in NADH signal
supports the notion that mitochondria in the kidney are in a
relatively oxidized state under resting conditions,14,40,41 a
scenario that might help to limit the rate of ROS production
by complex I of the respiratory chain.27 Cytosolic NADPH
has similar spectral properties to mitochondrial NADH;42
however, the majority of the blue autofluorescence signal
emitted by renal tubules originated from mitochondria, as
described in other aerobic tissues such as the heart22,37,43 and
skeletal muscle.38
FAD2þ is another endogenous mitochondrial fluorophore
that has been imaged using multiphoton microscopy in tissues
such as the heart22 and also provides information about the
mitochondrial redox state. It is optimally excited at longer
wavelengths such as 900 nm, as the green autofluorescence
signal is dominated by NADH at shorter wavelengths.22
Although we clearly identified a green autofluorescence
signal of mitochondrial origin in renal tubules, we were
unable to resolve characteristic changes in intensity expected in
FAD2þ signal because of respiratory chain inhibition during
ischemia;14 this may be because of factors such as the relatively
weak intrinsic fluorescence of FAD2þ , masking of the signal by
other sources of green autofluorescence, and the fact that the
green band-pass filter used in this study (495–540nm) may not
be optimal for detecting the emission spectra of FAD2þ , which
has a peak at B550 nm.44
We found that following intravenous injection of mito-
chondrial dyes, such as TMRM and HEt, sufficient loading
occurred in tubular cells to make useful physiological
observations and measurements. Previous in vitro experi-
ments in the rat kidney have suggested that the resting rate of
ROS production is higher in PT cells than in DT cells and
that the major sources of ROS generation are the mitochon-
drial respiratory chain and NADPH oxidases.14 In accordance
with this, we observed a higher fluorescence signal in the PT
following injection with the superoxide-sensitive dye HEt;
however, the signal localized to mitochondria only,
suggesting that they form the major source of ROS
generation in vivo, and we did not observe an increase in
HEt signal in nuclei, which occurred in isolated perfused
organs.15 At present, we cannot be sure of the reason(s) for
this in vivo versus in vitro difference, but possible
explanations might include differences in oxygen tension,
perfusion pressure, or composition of perfusate. The
explanation for a higher relatively HEt signal in the PT
mitochondria is also unclear at present. Mitochondrial ROS
levels are determined by the rate of generation and the
adequacy of antioxidant defenses; manganese superoxide
dismutase is a major mitochondrially targeted antioxidant,
and a previous study has demonstrated that manganese
superoxide dismutase expression levels are higher in DTs than
in PTs.45,46
Glutathione is an intracellular antioxidant with important
roles in drug metabolism in the PT, and MCB has been used
previously to take measurements of glutathione levels in renal
tubular cells,14 hepatocytes,47,48 cardiac myocytes,49,50 and
neurons.51–53 Although glutathione levels in PT cells in vitro
are determined solely by intracellular synthesis and
degradation, in vivo they are also affected by uptake of
circulating glutathione, which is synthesized in the liver. The
kidney removesB90% of circulating glutathione; glomerular
filtration accounts for less than a third of this; hence, PT
uptake has an important role in glutathione homeostasis.54 A
previous study has suggested that uptake occurs at the
basolateral PT membrane, via organic anion transporters or
sodium-coupled transport, with subsequent excretion across
the apical membrane to maintain intracellular glutathione
homeostasis.55,56 In agreement with this, we found that
MCB/glutathione was taken up by PT cells in vivo and was
then rapidly transported to the tubular lumen. We were
therefore unable to use MCB to make steady-state
intracellular measurements of glutathione levels in the PT;
however, it could potentially be utilized in future studies to
investigate changes in PT glutathione metabolism and
transport. In contrast to PTs, MCB fluorescence signal
remained stable in endothelial cells, suggesting that it could
be used to measure glutathione levels in the vasculature.
Relatively little fluorescence signal was observed in DTs
following MCB injection, consistent with previous studies,
suggesting that glutathione levels are lower in this nephron
segment than in the PT.56 MCB can react with several
intracellular low-molecular-weight thiols other than gluta-
thione; however, experiments conducted in hepatocytes
showed that only glutathione was in fact labeled by MCB.47
Furthermore, although high-performance liquid chromato-
graphy analysis of isolated PTs loaded with MCB revealed
evidence of cysteine– and mercapturate–MCB conjugates, in
addition to glutathione–MCB,55 it is more likely that the
existence of these was because of subsequent metabolism of
the glutathione–MCB conjugate, rather than because of direct
binding of cysteine and mercapturate to MCB.57
To fully exploit the translational potential of imaging
techniques, it is necessary to apply them to animal models of
human diseases. We have demonstrated that changes in
mitochondrial morphology and function can be imaged in
real time in rodent models of AKI. We observed alterations in
mitochondrial NADH signal and DCm in renal tubules in
response to ischemia reperfusion. During ischemia, the
activity of the ATP synthase within the mitochondria
reverses, and mitochondria become net consumers of ATP,
hydrolyzing it to pump protons out of the inner matrix.58,59
DCm can therefore be maintained to an extent during
ischemia in cells that can generate ATP via anaerobic
metabolism; however, glycolytic enzyme activity is very low
in PT cells.60 In keeping with previous studies in both kidney
slices14 and intact perfused organs,15 we found that DCm
dissipated rapidly in PTs in vivo following the onset of
ischemia, with very little further change over 30min. In
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contrast, DCm was better maintained in DTs, which have
greater glycolytic capacity and maintain higher levels of ATP
during ischemia.61 Interestingly, however, DCm dissipated
more quickly in DTs in vivo than in previous in vitro studies;
this phenomenon might be attributable to a higher rate of
ATP consumption in vivo (perhaps because of higher
temperature—the slice work was conducted at room
temperature). DCm was maintained to a significantly greater
extent in collecting ducts than in DTs after 30min of
ischemia, which could potentially be explained by a higher
capacity to generate ATP anaerobically in the former nephron
segment; experiments using isolated tubules have shown that
the distal convoluted tubule produces relatively less lactate
than the rest of the distal nephron when aerobic respiration is
compromised,62 for reasons that remain unclear.
Following an ischemic episode, cell death can subse-
quently occur in viable cells on reperfusion—the so-called
ischemia–reperfusion injury. Mitochondria are thought to
have a key role in the pathogenesis of this process,63,64 and
sustained defects in mitochondrial function have been
described in the PT following hypoxia and reoxygenation.6
We have demonstrated that changes in mitochondrial
structure and function within the renal tubules can be
imaged in real time during reperfusion, and this could
therefore potentially provide a powerful tool for studying the
mechanisms of ischemia–reperfusion in vivo and for evaluat-
ing the effectiveness of potential therapeutic interventions
(e.g. mitochondrially targeted antioxidants65). In agreement
with findings from a previous study using live kidney slices,
we found that mitochondria in the PT were fragmented
following ischemia–reperfusion and that the TMRM signal
was more heterogeneous across the cortex,2 possibly because
of variation in capillary flow resulting from microvascular
damage.66
Drug-induced damage is a major cause of AKI, and PT
mitochondria are frequently implicated as targets of toxi-
city.8,9,67 We explored the effects of gentamicin, a commonly
used aminoglycoside antibiotic, on mitochondrial structure
and function in the kidney in vivo. We observed
abnormalities in non-mitochondrial structures in PT cells
in the first 2 days of exposure, including enlargement of
lysosomes and increased autofluorescence signal in the brush
border (most likely reflecting accumulation of cellular
debris31); however, there was no significant change in mean
mitochondrial NADH signal or DCm during this time
period. After 4 days, sporadic areas of altered mitochon-
drial morphology and increased NADH signal were observed
in PTs, consistent with impaired respiratory chain activity.
These abnormalities became more widespread by 6 days, and
after 8 days frank necrosis occurred in PTs; in contrast,
mitochondrial structure and function were preserved in DTs
and collecting ducts.
Taken together, these observations are consistent with the
notion that gentamicin toxicity is specifically targeted to PT
and that mitochondrial dysfunction in the PT is a relatively
late event in the pathogenesis of gentamicin-induced AKI but
precedes the initiation of cell death. These findings are
generally supported by previous studies. In PT-derived llcpk
cells, gentamicin exposure caused an initial permeabilization
of lysosomal membranes, which was then followed by
dissipation of DCm, and subsequent activation of cell death
pathways.68 Studies using mitochondria isolated from the
renal cortex have shown that abnormalities in respiratory
chain function are relatively minor after 3–4 days of
gentamicin exposure but become more severe after 6
days.34,69 In addition, inhibitory effects of gentamicin on
respiratory chain activity were more marked with substrates
for complex I rather than for complex II;34 impairment of
complex I activity in vivo would push the mitochondrial
NAD pool into a more reduced state, a scenario that would
be consistent with the increased NADH signal that we
observed in damaged PTs.
Although we found that abnormalities in mitochondrial
structure and function in PTs generally occurred relatively
late in the time course of gentamicin toxicity, a striking
feature in our images was the high degree of variability both
among and within animals exposed to the same dosage
regime, as reported previously in histological studies.31,70
Mitochondrial abnormalities in PTs occurred in some, but
not all, animals after 4 days of exposure; at later time points
when damage was more widespread, grossly abnormal PTs
were observed to lie directly adjacent to healthy looking PTs,
whereas marked variations in signal occurred among cells
along the same tubule. Such a high degree of spatiotemporal
heterogeneity in mitochondrial damage is unlikely to be fully
appreciated by traditional means of assessing mitochondrial
function in the kidney (e.g. in vitro respiratory chain assays
using organelles isolated from kidney tissue).
There are some practical disadvantages to be considered
when using an in vivo approach to image mitochondrial
function in the kidney. Relatively large amounts of fluor-
escent dyes are required, and these cannot be delivered under
the controlled conditions of an in vitro or ex vivo preparation.
Therefore, greater heterogeneity of dye loading may be
observed, and achieving a steady state within cells is more
difficult; furthermore, some widely used AM ester dyes might
be cleaved by extracellular enzymes in vivo, thus limiting their
cellular uptake.71 Rhodamine 123 is a widely used DCm-
dependent dye that has been utilized previously to image
mitochondria in PTs and DTs in kidney slices;14 however, we
found that this dye did not load well into DTs in vivo for
reasons that are currently unclear. A small delayed increase in
rhodamine 123 fluorescence was observed in DT cells
following the appearance of filtered dye in tubular lumens,
suggesting that, unlike TMRM, rhodamine 123 uptake may
occur predominantly across the apical rather than basolateral
membrane in these cells. This phenomenon could explain in
part why rhodamine 123 uptake into DTs is greater in in vitro
models, in which dyes are loaded by bath application rather
than by vascular perfusion.
Some studies may therefore benefit initially from an
in vitro or ex vivo approach under more tightly controlled
80 Kidney International (2012) 83, 72–83
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conditions; however, it remains crucial that technological
tools are developed and refined to allow in vivo confirmation
of findings where possible in order to avoid inappropriate
attempts to translate purely in vitro phenomena to the
human situation. The usage of endogenous fluorophores,
such as NADH, can obviously circumvent difficulties related
to exogenous dye loading.
The native PT expresses an array of apical and basolateral
cell membrane transporters,72 which have the potential to
extrude fluorescent dyes. Indeed, although we observed that
the DCm-dependent dyes TMRM and rhodamine 123 were
rapidly taken up into tubular cells and localized to the
mitochondria, the fluorescence intensity subsequently
decayed over time. We confirmed that this was not because
of photobleaching, as the TMRM signal in DTs remained
constant. The identity of PT transporter(s) responsible for
extruding the dyes remains unknown at present, as inhibition
of either the MDR or organic cation transporters did not
prevent the signal decay.
In summary, we have demonstrated that mitochondrial
structure and function can be imaged in vivo in rodent
kidneys with multiphoton microscopy by using a combina-
tion of endogenous and exogenous fluorophores, and
changes in signal can be followed in real time in established
models of AKI. We have shown that this approach
simultaneously facilitates quantitative analysis of global
changes in mitochondrial function in situ across the renal
cortex with detailed qualitative examination of intracellular
morphology, crucially allowing the appreciation of variability
in signals among different tubules and cells, which can be
quite striking in diseases such as gentamicin toxicity. The
potential now exists for future studies to combine measure-
ments of mitochondrial function with other readouts in the
multiphoton imaging toolkit—including blood flow, glomer-
ular filtration rate, tubular flow, and solute transport—to




All experiments were conducted in accordance with NIH Guidelines
and were approved by the Institutional Animal Care and Use
Committee. Adult male C57 mice (Harlan Labs, Indianapolis, IN) or
Sprague–Dawley rats (Harlan Labs) were used (except for experi-
ments in which Munich–Wistar rats were utilized to image
superficial glomeruli). Mice weighing 20–20 g were anesthetized
with inhaled isoflurane (2%), whereas rats weighing 250–400 g were
anesthetized by intraperitoneal injection with thiobutabarbital
sodium (Sigma Aldrich, St Louis, MO) at a dose of 160mg/kg.
They were then placed on a warming table to maintain a core
temperature of 37 1C, which was monitored throughout the
experiment using a rectal thermometer. The right internal jugular
vein was cannulated to allow the injection of fluorescent dyes.
For ischemia–reperfusion experiments, after shaving the abdo-
men of the rat a midline incision was made through the skin and
musculature to expose the abdominal cavity. The left renal artery
was isolated through blunt dissection, and a 3.0 silk suture was
placed around the vessel and passed through a length of
polyethylene tubing that exited the abdominal cavity. The abdomen
was then closed around the tubing. To induce ischemia, the tension
on the two ends of the thread was increased until there was a visible
cessation of kidney perfusion; the tension was subsequently relaxed
to allow reperfusion. The left kidney was externalized via a lateral
incision and imaged using methods described previously.73 For
gentamicin toxicity experiments, adult male Sprague–Dawley rats
weighing 250–350 g were given a daily intraperitoneal injection of
gentamicin (Sigma Aldrich) at a dose of 100mg/kg, as per a
previously established protocol.36
Dye loading and microscope settings
Images were acquired using an inverted Fluoview 1000 Olympus
microscope adapted for multiphoton microscopy (Olympus Cor-
poration, Tokyo, Japan) and either 20 or 60 objectives.
Fluorescent dyes were administered via intravenous injection. HEt
(200 mg/ml) (Invitrogen Molecular Probes, Eugene, OR), endogen-
ous NADH, and MCB (5mg/ml) (Invitrogen Molecular Probes)
were excited at wavelengths of 720–760 nm. TMRM (5 mg/ml) and
rhodamine 123 (6mg/ml) (Invitrogen Molecular Probes) were
excited at wavelengths of 800–850 nm. Emitted light was collected
using three fixed band-pass filters: 420–460 nm (blue), 495–540 nm
(green), and 575–630 nm (red). For experiments involving inhibitors
of renal transporters, verapamil (Sigma Aldrich) was used at a dose
of 1mg/kg body weight, whereas cimetidine (Sigma Aldrich) was
used at a fixed dose of 8 mmoles (0.2ml of a 40 mM solution) per
animal.
Image analysis and statistics
Images were processed using Image J software (National Institutes of
Health, MD, http://rsb.info.nih.gov/ij/). Regions of interest were
drawn around tubules to obtain mean fluorescence signals.
Mitochondrial signals were isolated by setting a threshold level to
remove the background cytosolic fluorescence. Images were
acquired within 5min of intravenous dye injection, as some signals
decayed with time. To account for movement in the z plane during
ischemia experiments, images were collected in serial z-stacks and
reconstructed to a signal-averaged 2D image using imaging software.
For the gentamicin experiments, fields of PTs were chosen randomly
using the green autofluorescence channel before obtaining NADH
and TMRM signals. The results are presented as means±s.e.m.
Statistical differences among study groups were explored using one-
way analysis of variance and groups were compared using the paired
or unpaired t-test as appropriate; a P value ofo0.05 was considered
significant.
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